Commercial clinical trials review response
The government published its initial response to the Lord O’Shaughnessy review into UK commercial clinical trials in May 2023. The initial response welcomed all recommendations. This report details the response in full and integrates Lord O’Shaughnessy’s recommendations into the government’s work to implement Saving and Improving Lives: The Future of UK Clinical Research Delivery.